Acquisitions & Investments
Approach
Bioventus deploys an end-to-end merger & acquisition (“M&A”) and investment capability that includes identification, transaction structure, execution, due diligence and integration. Bioventus is a preferred partner to companies, owners and management teams because we devise creative transactional solutions, have a nimble governance and decision-making process, and draw on an extensive track record of successful M&A.
All M&A and investment opportunities should be directed to our Business Development team either directly or through the website submission form below.
Investment Criteria
- Differentiated technologies backed by clinical evidence
- Consistent double-digit revenue growth
- Attractive gross margin profile
- Return on invested capital (“ROIC”) accretive by year 5
- Path to near term cash earnings accretion
- Ability to drive global strategy
Areas of Interest
- Pain therapies to reduce opioid usage
- Minimally invasive surgical devices
- Sports medicine
- Spine and neurosurgery
- Foot and ankle
- Diabetic foot ulcer treatments
Note: Above criteria and areas are directional.
Submit Proposal
To submit an acquisition proposals on a NON-CONFIDENTIAL basis, please complete the form below. Please note, Bioventus will be under no obligation to treat any information provided in this manner as confidential regardless of any legend or statement contained therein or set forth with respect thereto. Following submission, a member of the Bioventus Business Development team will promptly respond to your submission.
